BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37249427)

  • 1. Effectiveness of US Surveillance of Hepatocellular Carcinoma in Chronic Hepatitis B: US LI-RADS Visualization Score.
    Park MK; Lee DH; Hur BY; Lee HC; Lee YB; Yu SJ; Kim YJ; Yoon JH; Lee JH
    Radiology; 2023 Jun; 307(5):e222106. PubMed ID: 37249427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of US Liver Imaging Reporting and Data System Version 2017 in Patients at High Risk for Hepatocellular Carcinoma.
    Son JH; Choi SH; Kim SY; Jang HY; Byun JH; Won HJ; Lee SJ; Lim YS
    Radiology; 2019 Aug; 292(2):390-397. PubMed ID: 31210614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved detection of hepatocellular carcinoma by dynamic computed tomography in cirrhotic patients with chronic hepatitis B: A multicenter study.
    Kim JH; Kang SH; Lee M; Choi HS; Jun BG; Kim TS; Choi DH; Suk KT; Kim MY; Kim YD; Cheon GJ; Baik SK; Kim DJ
    J Gastroenterol Hepatol; 2020 Oct; 35(10):1795-1803. PubMed ID: 32222111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCC screening with ultrasound: assessment of quality using ultrasound LI-RADS score.
    King MJ; Lee KM; Rosberger S; Huang HH; Meza GH; Lewis S; Taouli B
    Abdom Radiol (NY); 2023 Jan; 48(1):263-270. PubMed ID: 36243829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B.
    Shin H; Jung YW; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Kim YY; Choi JY; Kim SU
    Clin Mol Hepatol; 2019 Dec; 25(4):390-399. PubMed ID: 31146508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis.
    van der Pol CB; McInnes MDF; Salameh JP; Levis B; Chernyak V; Sirlin CB; Bashir MR; Allen BC; Burke LMB; Choi JY; Choi SH; Forner A; Fraum TJ; Giamperoli A; Jiang H; Joo I; Kang Z; Kierans AS; Kang HJ; Khatri G; Kim JH; Kim MJ; Kim SY; Kim YY; Kwon H; Lee JM; Lewis SC; McGinty KA; Mulazzani L; Park MS; Piscaglia F; Podgórska J; Reiner CS; Ronot M; Rosiak G; Song B; Song JS; Tang A; Terzi E; Wang J; Wang W; Wilson SR; Yokoo T
    Radiology; 2022 Feb; 302(2):326-335. PubMed ID: 34783596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma.
    Huang JY; Li JW; Lu Q; Luo Y; Lin L; Shi YJ; Li T; Liu JB; Lyshchik A
    Radiology; 2020 Feb; 294(2):329-339. PubMed ID: 31793849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic value of contrast-enhanced ultrasound LI-RADS for hepatocellular carcinoma in patients with cirrhosis and chronic hepatitis B.
    Yang D; Hu H; Li R; Tang CL; Ma KS; Guo DY
    Abdom Radiol (NY); 2022 Feb; 47(2):630-639. PubMed ID: 34910237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LI-RADS Version 2017 versus Version 2018: Diagnosis of Hepatocellular Carcinoma on Gadoxetate Disodium-enhanced MRI.
    Lee SM; Lee JM; Ahn SJ; Kang HJ; Yang HK; Yoon JH
    Radiology; 2019 Sep; 292(3):655-663. PubMed ID: 31310175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of LI-RADS Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma in Liver Transplant Candidates: Intraindividual Comparison between CT and Hepatobiliary Agent-enhanced MRI.
    Bae JS; Lee JM; Yoon JH; Kang HJ; Jeon SK; Joo I; Lee KB; Kim H
    Radiology; 2021 May; 299(2):336-345. PubMed ID: 33650901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors and Cumulative Frequency of Hepatocellular Carcinoma in High and Intermediate LI-RADS Lesions: A Cohort Study from a Canadian Academic Institution.
    Tang ES; Hall G; Yu D; Menard A; Hopman W; Nanji S
    Ann Surg Oncol; 2019 Aug; 26(8):2560-2567. PubMed ID: 31025229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACR Ultrasound Liver Reporting and Data System: Multicenter Assessment of Clinical Performance at One Year.
    Millet JD; Kamaya A; Choi HH; Dahiya N; Murphy PM; Naveed MZ; O'Boyle M; Parra LA; Perez MG; Pirmoazen AM; Rodgers SK; Wasnik AP; Maturen KE
    J Am Coll Radiol; 2019 Dec; 16(12):1656-1662. PubMed ID: 31173745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing Adherence to US LI-RADS Follow-up Recommendations in Vulnerable Patients Undergoing Hepatocellular Carcinoma Surveillance.
    Choi HH; Kim S; Shum DJ; Huang CY; Shui A; Fox RK; Khalili M
    Radiol Imaging Cancer; 2024 Jan; 6(1):e230118. PubMed ID: 38214600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound (US) LI-RADS: Outcomes of Category US-3 Observations.
    Sevco TJ; Masch WR; Maturen KE; Mendiratta-Lala M; Wasnik AP; Millet JD
    AJR Am J Roentgenol; 2021 Sep; 217(3):644-650. PubMed ID: 34259543
    [No Abstract]   [Full Text] [Related]  

  • 15. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
    Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
    J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Performance of 2018 KLCA-NCC Practice Guideline for Hepatocellular Carcinoma on Gadoxetic Acid-Enhanced MRI in Patients with Chronic Hepatitis B or Cirrhosis: Comparison with LI-RADS Version 2018.
    Lee SM; Lee JM; Ahn SJ; Kang HJ; Yang HK; Yoon JH
    Korean J Radiol; 2021 Jul; 22(7):1066-1076. PubMed ID: 33739633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced US with Perfluorobutane for Hepatocellular Carcinoma Surveillance: A Multicenter Diagnostic Trial (SCAN).
    Park JH; Park MS; Lee SJ; Jeong WK; Lee JY; Park MJ; Lee SS; Han K; Nam CM; Park SH; Lee KH
    Radiology; 2019 Sep; 292(3):638-646. PubMed ID: 31287387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LI-RADS v2017 categorisation of HCC using CT: Does moderate to severe fatty liver affect accuracy?
    Kim SS; Hwang JA; Shin HC; Choi SY; Kang TW; Jou SS; Lee WH; Park S; Heo NH
    Eur Radiol; 2019 Jan; 29(1):186-194. PubMed ID: 30073499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound Liver Imaging Reporting and Data System (US LI-RADS) Visualization Score: a reliability analysis on inter-reader agreement.
    Tiyarattanachai T; Bird KN; Lo EC; Mariano AT; Ho AA; Ferguson CW; Chima RS; Desser TS; Morimoto LN; Kamaya A
    Abdom Radiol (NY); 2021 Nov; 46(11):5134-5141. PubMed ID: 34228197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter Study of ACR Ultrasound LI-RADS Visualization Scores on Serial Examinations: Implications for Surveillance Strategies.
    Tiyarattanachai T; Fetzer DT; Kamaya A
    AJR Am J Roentgenol; 2022 Sep; 219(3):445-452. PubMed ID: 35383486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.